English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Dec 19, 2025
Nektar reviews mid-stage data after alopecia drug misses main goal
Patient Daily
| Dec 19, 2025
Roche’s Genentech partners with Caris Life Sciences on cancer drug discovery
Patient Daily
| Dec 19, 2025
Addition Therapy launches with $100M aiming for one-time treatments for rare diseases
Patient Daily
| Dec 19, 2025
New chip enables rapid assessment of brain cancer therapy effectiveness
Patient Daily
| Dec 19, 2025
UVA study links traumatic brain injury with increased Alzheimer’s risk through impaired lymphatic drainage
Patient Daily
| Dec 19, 2025
Penn State researchers find opposing protein actions affect mRNA stability in human cells
Patient Daily
| Dec 19, 2025
University of Utah researchers identify gut bacterium linked to reduced weight gain in mice
Patient Daily
| Dec 19, 2025
MEA-based graph modeling detects early brain connectivity changes related to autism risk
Trending
+
Pharmaceuticals
Patient Daily
| Apr 5, 2026
Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily
| Apr 7, 2026
ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+
Regulatory
Patient Daily
| Apr 9, 2026
Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+
Regulatory
Patient Daily
| Apr 8, 2026
Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
« First
«
…
106
107
108
109
110
111
112
…
»
Last »